Suppr超能文献

糖原贮积病的临床前研究:当前动物模型的综合综述。

Preclinical Research in Glycogen Storage Diseases: A Comprehensive Review of Current Animal Models.

机构信息

Mitochondrial and Neuromuscular Disorders Unit, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.

Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain.

出版信息

Int J Mol Sci. 2020 Dec 17;21(24):9621. doi: 10.3390/ijms21249621.

Abstract

GSD are a group of disorders characterized by a defect in gene expression of specific enzymes involved in glycogen breakdown or synthesis, commonly resulting in the accumulation of glycogen in various tissues (primarily the liver and skeletal muscle). Several different GSD animal models have been found to naturally present spontaneous mutations and others have been developed and characterized in order to further understand the physiopathology of these diseases and as a useful tool to evaluate potential therapeutic strategies. In the present work we have reviewed a total of 42 different animal models of GSD, including 26 genetically modified mouse models, 15 naturally occurring models (encompassing quails, cats, dogs, sheep, cattle and horses), and one genetically modified zebrafish model. To our knowledge, this is the most complete list of GSD animal models ever reviewed. Importantly, when all these animal models are analyzed together, we can observe some common traits, as well as model specific differences, that would be overlooked if each model was only studied in the context of a given GSD.

摘要

GSD 是一组疾病,其特征是参与糖原分解或合成的特定酶的基因表达缺陷,通常导致糖原在各种组织(主要是肝脏和骨骼肌)中积累。已经发现几种不同的 GSD 动物模型具有自然发生的突变,还有一些已经开发和表征,以便进一步了解这些疾病的病理生理学,并作为评估潜在治疗策略的有用工具。在本工作中,我们总共回顾了 42 种不同的 GSD 动物模型,包括 26 种基因修饰的小鼠模型、15 种自然发生的模型(包括鹌鹑、猫、狗、绵羊、牛和马)和 1 种基因修饰的斑马鱼模型。据我们所知,这是迄今为止对 GSD 动物模型最全面的综述。重要的是,当所有这些动物模型一起分析时,我们可以观察到一些共同的特征,以及特定于模型的差异,如果仅在给定 GSD 的背景下研究每个模型,这些特征和差异可能会被忽略。

相似文献

1
Preclinical Research in Glycogen Storage Diseases: A Comprehensive Review of Current Animal Models.
Int J Mol Sci. 2020 Dec 17;21(24):9621. doi: 10.3390/ijms21249621.
2
Glycogen storage diseases in animals and their potential value as models of human disease.
J Inherit Metab Dis. 1983;6(1):3-16. doi: 10.1007/BF02391186.
3
Large animal models and new therapies for glycogen storage disease.
J Inherit Metab Dis. 2015 May;38(3):505-9. doi: 10.1007/s10545-014-9766-8. Epub 2014 Sep 16.
6
Glycogen storage disease: clinical, biochemical, and molecular heterogeneity.
Semin Pediatr Neurol. 2006 Jun;13(2):115-20. doi: 10.1016/j.spen.2006.06.007.
9
Glycogen storage diseases: An update.
World J Gastroenterol. 2023 Jul 7;29(25):3932-3963. doi: 10.3748/wjg.v29.i25.3932.
10
Bulbar muscle weakness and fatty lingual infiltration in glycogen storage disorder type IIIa.
Mol Genet Metab. 2012 Nov;107(3):496-500. doi: 10.1016/j.ymgme.2012.09.025. Epub 2012 Sep 28.

引用本文的文献

4
Cardiovascular involvement in glycogen storage diseases.
Nat Rev Cardiol. 2025 Jun 5. doi: 10.1038/s41569-025-01171-w.
5
Zebrafish navigating the metabolic maze: insights into human disease - assets, challenges and future implications.
J Diabetes Metab Disord. 2024 Dec 16;24(1):3. doi: 10.1007/s40200-024-01539-8. eCollection 2025 Jun.
7
Gene therapy for glycogen storage diseases.
J Inherit Metab Dis. 2024 Jan;47(1):93-118. doi: 10.1002/jimd.12654. Epub 2023 Jul 27.
8
Degeneration of muscle spindles in a murine model of Pompe disease.
Sci Rep. 2023 Apr 21;13(1):6555. doi: 10.1038/s41598-023-33543-y.
9
The Serotonergic System and Amyotrophic Lateral Sclerosis: A Review of Current Evidence.
Cell Mol Neurobiol. 2023 Aug;43(6):2387-2414. doi: 10.1007/s10571-023-01320-0. Epub 2023 Feb 2.

本文引用的文献

2
Pompe Disease: New Developments in an Old Lysosomal Storage Disorder.
Biomolecules. 2020 Sep 18;10(9):1339. doi: 10.3390/biom10091339.
3
Results of an open label feasibility study of sodium valproate in people with McArdle disease.
Neuromuscul Disord. 2020 Sep;30(9):734-741. doi: 10.1016/j.nmd.2020.04.009. Epub 2020 May 16.
4
A Novel Gene Therapy Approach for GSD III Using an AAV Vector Encoding a Bacterial Glycogen Debranching Enzyme.
Mol Ther Methods Clin Dev. 2020 Jun 2;18:240-249. doi: 10.1016/j.omtm.2020.05.034. eCollection 2020 Sep 11.
6
Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase.
Mol Ther. 2020 Sep 2;28(9):2056-2072. doi: 10.1016/j.ymthe.2020.05.025. Epub 2020 May 30.
7
Lentiviral Hematopoietic Stem Cell Gene Therapy Corrects Murine Pompe Disease.
Mol Ther Methods Clin Dev. 2020 May 4;17:1014-1025. doi: 10.1016/j.omtm.2020.04.023. eCollection 2020 Jun 12.
8
Gene therapy using a novel G6PC-S298C variant enhances the long-term efficacy for treating glycogen storage disease type Ia.
Biochem Biophys Res Commun. 2020 Jun 30;527(3):824-830. doi: 10.1016/j.bbrc.2020.04.124. Epub 2020 May 16.
9
Animal Model Contributions to Congenital Metabolic Disease.
Adv Exp Med Biol. 2020;1236:225-244. doi: 10.1007/978-981-15-2389-2_9.
10
Beneficial Effects of Ketogenic Diet on Phosphofructokinase Deficiency (Glycogen Storage Disease Type VII).
Front Neurol. 2020 Feb 4;11:57. doi: 10.3389/fneur.2020.00057. eCollection 2020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验